CPOP-R Versus CHOP-R As First-Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): A Phase 2, Randomized, Open-Label, Multicenter Study

R Herbrecht; D MacDonald; F Weissinger; Martin Wilhelm; C Holladay; NH Dang; P Holman; P Cernohous; J Singer; RH van der Jagt

CPOP-R Versus CHOP-R As First-Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): A Phase 2, Randomized, Open-Label, Multicenter Study

R Herbrecht, D MacDonald, F Weissinger, Martin Wilhelm, C Holladay, NH Dang, P Holman, P Cernohous, J Singer, RH van der Jagt

Department of Internal Medicine V, Division of Oncology and Hematology

Research output: Contribution to journal › Abstract (Journal) › peer-review

1 Citation (Web of Science)

Original language	English
Pages (from-to)	697-698
Journal	BLOOD
Volume	118
Issue number	21
Publication status	Published - 2011
Event	53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis - San Diego, CA Duration: 10 Dec 2011 → 13 Dec 2011

Cite this

Herbrecht, R., MacDonald, D., Weissinger, F., Wilhelm, M., Holladay, C., Dang, NH., Holman, P., Cernohous, P., Singer, J., & van der Jagt, RH. (2011). CPOP-R Versus CHOP-R As First-Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): A Phase 2, Randomized, Open-Label, Multicenter Study. BLOOD , 118(21), 697-698.

Herbrecht, R ; MacDonald, D ; Weissinger, F et al. / CPOP-R Versus CHOP-R As First-Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): A Phase 2, Randomized, Open-Label, Multicenter Study. In: BLOOD 2011 ; Vol. 118, No. 21. pp. 697-698.

@article{122b8601d533469aa35616700ecfc154,

title = "CPOP-R Versus CHOP-R As First-Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): A Phase 2, Randomized, Open-Label, Multicenter Study",

author = "R Herbrecht and D MacDonald and F Weissinger and Martin Wilhelm and C Holladay and NH Dang and P Holman and P Cernohous and J Singer and {van der Jagt}, RH",

year = "2011",

language = "English",

volume = "118",

pages = "697--698",

journal = "BLOOD ",

issn = "0006-4971",

publisher = "American Society of Hematology ",

number = "21",

note = "53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis ; Conference date: 10-12-2011 Through 13-12-2011",

}

Herbrecht, R, MacDonald, D, Weissinger, F, Wilhelm, M, Holladay, C, Dang, NH, Holman, P, Cernohous, P, Singer, J & van der Jagt, RH 2011, 'CPOP-R Versus CHOP-R As First-Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): A Phase 2, Randomized, Open-Label, Multicenter Study', BLOOD , vol. 118, no. 21, pp. 697-698.

CPOP-R Versus CHOP-R As First-Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): A Phase 2, Randomized, Open-Label, Multicenter Study. / Herbrecht, R; MacDonald, D; Weissinger, F et al.
In: BLOOD , Vol. 118, No. 21, 2011, p. 697-698.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - CPOP-R Versus CHOP-R As First-Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): A Phase 2, Randomized, Open-Label, Multicenter Study

AU - Herbrecht, R

AU - MacDonald, D

AU - Weissinger, F

AU - Wilhelm, Martin

AU - Holladay, C

AU - Dang, NH

AU - Holman, P

AU - Cernohous, P

AU - Singer, J

AU - van der Jagt, RH

PY - 2011

Y1 - 2011

M3 - Abstract (Journal)

SN - 0006-4971

VL - 118

SP - 697

EP - 698

JO - BLOOD

JF - BLOOD

IS - 21

T2 - 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis

Y2 - 10 December 2011 through 13 December 2011

ER -

Herbrecht R, MacDonald D, Weissinger F, Wilhelm M, Holladay C, Dang NH et al. CPOP-R Versus CHOP-R As First-Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): A Phase 2, Randomized, Open-Label, Multicenter Study. BLOOD . 2011;118(21):697-698.